K.A. Orrell

Inflammatory bowel disease events after exposure to interleukin 17 inhibitors secukinumab and ixekizumab: Postmarketing analysis from the RADAR (“Research on Adverse Drug events And Reports”) program

K.A. Orrell, Morgan Murphrey, Ryan C. Kelm et al. · Journal of the American Academy of Dermatology · 2018 · 37 citations · Full text

Inflammation, “ Research, Allergy +9

Malignant melanoma associated with chronic once-daily aspirin exposure in males: A large, single-center, urban, US patient population cohort study from the “Research on Adverse Drug events And Report” (RADAR) project

K.A. Orrell, Ahuva Cices, Nicholas J. Guido et al. · Journal of the American Academy of Dermatology · 2018 · 17 citations

Melanoma, Clinical Epidemiology, Adverse Drug Events +7

Inverse association for diagnosis of Alzheimer's disease subsequent to both melanoma and non‐melanoma skin cancers in a large, urban, single‐centre, Midwestern <scp>US</scp> patient population

Erin Ibler, Genevieve P. Tran, K.A. Orrell et al. · Journal of the European Academy of Dermatology and Venereology · 2018 · 16 citations

Risks for noncutaneous second primary malignancy in cutaneous malignant melanoma survivors: an analysis of data from the Surveillance, Epidemiology, and End Results (SEER) program

Paras P. Vakharia, Ryan C. Kelm, K.A. Orrell et al. · International Journal of Dermatology · 2020 · 14 citations

Skin Damage Prevention Strategies During COVID-19: Assessing Their Effect on N95 Mask Seal Integrity

Perla Lansang, K.A. Orrell, Jennifer Tran et al. · Journal of Cutaneous Medicine and Surgery · 2020 · 13 citations · Full text

Vaccination, Cutaneous Biology, Infection Control +3